#USA #Plantation #BioMatrix #Transplant Services #Heidi Ulbrich

BioMatrix Infusion Pharmacy Promotes Heidi Ulbrich

In a strategic move aimed at bolstering its transplant services, BioMatrix Infusion Pharmacy has appointed Heidi Ulbrich, BSN, RN, CCTC, as its new Transplant Services Program Manager. This promotion is not merely a reflection of Ulbrich's qualifications but also underscores BioMatrix's commitment to providing exceptional care for transplant patients who navigate complex clinical and logistical challenges.

Expertise That Transforms Care

Heidi Ulbrich brings a wealth of knowledge and experience to her new role. With her background encompassing both inpatient management and outpatient infusion therapy, she stands out as a certified clinical transplant coordinator, accredited by the American Board for Transplant Certification.

Previously, Ulbrich functioned as a Clinical Nurse Liaison for solid organ transplantation, connecting transplant centers, pharmacy teams, and stakeholders seamlessly. This experience will now serve her well as she takes on a broader responsibility in overseeing operations for BioMatrix’s transplant program.

In her capacity as Program Manager, Heidi will ensure that the transplant services offered are not only comprehensive but are also executed with the utmost precision. This includes fostering relationships with transplant centers and referring providers, while also coordinating with internal clinical teams to maintain consistent care delivery across the network of BioMatrix pharmacies.

Growth Catalyst in Transplant Services

Ulbrich’s promotion coincides with significant growth in BioMatrix's transplant division. The pharmacy supported over 800 transplant patients across 42 states in 2025, showcasing their capacity to manage a growing patient population. This growth reflects both the trust placed in BioMatrix by referral partners and the pharmacy's commitment to expanding their services responsibly.

Despite the rapid growth, BioMatrix is adamant about maintaining their 'white-glove' service approach, essential for the sensitive nature of transplant patient needs. They pride themselves on their industry-leading initiation of care, promising therapy commencement within 14 days of referral. This is facilitated by a combination of robust infrastructure, including:

• - High-acuity Support: Designed to accommodate pre-transplant desensitization and post-transplant infusion therapies.
• - Dedicated Prior Authorization Team: This team helps navigate the complexities associated with coverage requirements relevant to transplant patients.
• - Close Coordination: Efforts with transplant centers and care teams are made to eliminate potential delays in patient care.

A Commitment to Excellence

“The promotion of Heidi reflects our long-term strategy and commitment to transplant care,” stated Ted Kramm, CEO of BioMatrix Infusion Pharmacy. “In this field, there is no room for inefficiency; every day is critical, and every handoff matters. We’ve developed systems that acknowledge and respect that urgency.”

BioMatrix Infusion Pharmacy has established itself as a leader in the independent infusion pharmacy space, equipped with years of experience. Their compassionate team remains focused on helping patients through the challenges posed by the healthcare environment, working closely with patients, families, and healthcare providers to achieve optimal clinical outcomes.

For those seeking to learn more about BioMatrix and their services, the company encourages visits to their website. Each day, they dedicate their efforts to making a significant difference in the lives of people they serve, solidifying their role as a trusted healthcare partner.